Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion type Assertion NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_head.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion wasGeneratedBy ECO_0000203 NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_provenance.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion wasDerivedFrom befree-2016 NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_provenance.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion SIO_000772 14967078 NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_provenance.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion evidence source_evidence_literature NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_provenance.
- NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_assertion description "[Clinical efficacy of COX-2 inhibitors in the treatment of NSCLC is presently undergoing evaluation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431973.RAzIeb8fINlNm966HlP0mmDKRclZhB-i2OywFNQ4PIR7A130_provenance.